Volume 42 Issue 1, January 2024

Researchers in low- and middle-income countries are developing their own IP, scaling up local manufacturing, and looking for biomarkers — all in the hope of bringing costs down and getting therapies to people who need them.

More can be done to diversify the AI innovation ecosystem, especially in the emerging field of biotechnology AI, where women’s participation is associated with substantial value.

Recent patents relating to generating transgenic animals, tissues and cells for xenotransplantation.

A computational pipeline enables differential V(D)J usage analysis and pseudotime trajectory inference from single-cell AIR sequencing.

Mapping DNA-associated disordered proteins across the genome uncovers gene regulatory patterns.

Imaging of large, cleared samples in diverse media is achieved using a mirror objective.

tRNA abundance and chemical modifications are measured simultaneously with nanopores.

Large DNA sequences are integrated into human cells using RNA-guided CRISPR-associated transposases.

cellDancer enables RNA velocity estimation with cell-specific kinetics.

An atlas of noncoding RNA in aging and rejuvenated mice identifies a set of deregulated miRNAs.

Immunoprecipitation coupled with paired-end sequencing of non-coding RNAs identifies a class of splicing regulators.

A sequencing chemistry that separates nucleotide identification from nucleotide incorporation achieves high accuracy.

Phylogenetic trees are generated from sequencing reads without genome assembly or annotation.

An intensive summer training program increased enrollment in a Master of Science in Biotechnology degree program, increasing awareness and opportunities among under-represented and underserved groups as a first step to transforming the biotech industry.

Recent moves of note in and around the biotech and pharma industries.